rs74315335
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM2_SupportingPS4_SupportingPP1_ModeratePP3
This summary comes from the ClinGen Evidence Repository: The c.1010A>G variant in MYOC is a missense variant predicted to cause substitution of Glutamine by Arginine at amino acid 337 (p.Gln337Arg). This variant was not found in any population of gnomAD (v2.1.1), meeting the ≤ 0.0001 threshold set for PM2_Supporting in a population of at least 10,000 alleles. The REVEL score = 0.743, which met the ≥ 0.7 threshold for PP3, predicting a damaging effect on MYOC function. There was no functional evidence predicting a damaging or benign impact of this variant on MYOC function. 6 segregations in 2 families, with juvenile or primary open angle glaucoma (JOAG or POAG), have been reported (PMIDs: 34923728, 9361308), which fulfilled PP1_Moderate (≥5 meioses). 4 probands with JOAG or POAG have been reported carrying this variant (PMIDs: 34923728, 32300215, 9361308), which met PS4_Supporting (≥ 2 probands). In summary, this variant met the criteria to receive a score of 5 and to be classified as a variant of uncertain significance (uncertain significance classification range -1 to 5) for juvenile open angle glaucoma based on the ACMG/AMP criteria met, as specified by the ClinGen Glaucoma VCEP (v1, 12 Oct 2021): PP1_Moderate, PP3, PS4_Supporting, PM2_Supporting LINK:https://erepo.genome.network/evrepo/ui/classification/CA119177/MONDO:0020367/019
Frequency
Consequence
NM_000261.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYOC | NM_000261.2 | c.1010A>G | p.Gln337Arg | missense_variant | 3/3 | ENST00000037502.11 | NP_000252.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYOC | ENST00000037502.11 | c.1010A>G | p.Gln337Arg | missense_variant | 3/3 | 1 | NM_000261.2 | ENSP00000037502.5 | ||
MYOCOS | ENST00000637303.1 | c.235-2200T>C | intron_variant | 5 | ENSP00000490048.1 | |||||
MYOC | ENST00000638471.1 | n.*348A>G | non_coding_transcript_exon_variant | 4/4 | 5 | ENSP00000491206.1 | ||||
MYOC | ENST00000638471.1 | n.*348A>G | 3_prime_UTR_variant | 4/4 | 5 | ENSP00000491206.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461892Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 727246
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Glaucoma 1, open angle, A Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Sep 01, 1997 | - - |
Glaucoma of childhood Uncertain:1
Uncertain significance, reviewed by expert panel | curation | ClinGen Glaucoma Variant Curation Expert Panel | Aug 07, 2023 | The c.1010A>G variant in MYOC is a missense variant predicted to cause substitution of Glutamine by Arginine at amino acid 337 (p.Gln337Arg). This variant was not found in any population of gnomAD (v2.1.1), meeting the <= 0.0001 threshold set for PM2_Supporting in a population of at least 10,000 alleles. The REVEL score = 0.743, which met the >= 0.7 threshold for PP3, predicting a damaging effect on MYOC function. There was no functional evidence predicting a damaging or benign impact of this variant on MYOC function. 6 segregations in 2 families, with juvenile or primary open angle glaucoma (JOAG or POAG), have been reported (PMIDs: 34923728, 9361308), which fulfilled PP1_Moderate (>=5 meioses). 4 probands with JOAG or POAG have been reported carrying this variant (PMIDs: 34923728, 32300215, 9361308), which met PS4_Supporting (>= 2 probands). In summary, this variant met the criteria to receive a score of 5 and to be classified as a variant of uncertain significance (uncertain significance classification range -1 to 5) for juvenile open angle glaucoma based on the ACMG/AMP criteria met, as specified by the ClinGen Glaucoma VCEP (v1, 12 Oct 2021): PP1_Moderate, PP3, PS4_Supporting, PM2_Supporting - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at